Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CIPROFLOXACIN EXTENDED RELEASE
- Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition
- Modified Surface of PLGA Nanoparticles in Smart Hydrogel
- Effect of Double Antibiotic Paste Versus Calcium Hydroxide on RANKL/OPG Levels
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- The Role of the Microbiota in the Systemic Immune Response
- Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome
- The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia
- Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality
- Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure
- Prostate Biopsy Antisepsis
- Impact of Formulation on Ciprofloxacin Oral Absorption
- BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
- Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
- Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
- Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
- Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg
- Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas
Clinical trials list
click for details